95 related articles for article (PubMed ID: 2477953)
1. [Antitumor effect of the Soviet recombinant alpha2-interferon (reaferon) under experimental conditions].
Lavrukhina LA; Posevaia TA; Barinskiĭ IF; Ershov FI
Vopr Virusol; 1989; 34(3):312-5. PubMed ID: 2477953
[TBL] [Abstract][Full Text] [Related]
2. [The antitumor action of double-stranded interferon inducers (larifan, ridostin) and reaferon in an experiment].
Barinskiĭ IF; Posevaia TA; Lavrukhina LA; Kosiakova NP
Vopr Virusol; 1994; 39(4):179-82. PubMed ID: 7998398
[TBL] [Abstract][Full Text] [Related]
3. [Action of Soviet chemical preparations, reaferon and inducers on the reproduction of HTLV-III retrovirus].
Barinskiĭ IF; Gribencha SV; Nesterchuk SL; Zhdanov VM
Vopr Virusol; 1987; 32(5):561-5. PubMed ID: 3433714
[TBL] [Abstract][Full Text] [Related]
4. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B].
Andreĭchin MA; Rudchik AS; Borak VF
Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572
[TBL] [Abstract][Full Text] [Related]
5. [The dynamic production of interferons, interleukins and arachidonic acid metabolites by the blood cells of children with glomerulonephritis associated with HB virus infection while treated with reaferon].
Markarian AS; Malinovskaia VV; Dlin VV; Ignatov MS; Asratian AA; Pronin AV
Vopr Virusol; 1993; 38(4):152-6. PubMed ID: 7694426
[TBL] [Abstract][Full Text] [Related]
6. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
[TBL] [Abstract][Full Text] [Related]
7. [Clinical response to combined treatment with reaferon and iodantipirin in patients with chronic HCV- and HBV-infection].
Beloborodova EI; Vnushinskaia MA; Rachkovskiĭ MI; Shalovaĭ AA; Timoshchuk OA; Khudoleĭ NV
Klin Med (Mosk); 2002; 80(4):52-4. PubMed ID: 12043266
[TBL] [Abstract][Full Text] [Related]
8. [Reaferon in the treatment of hemorrhagic fever with the renal syndrome].
Ivanov KS; Roshchupkin VI; Koshil' OI; Morozov VG; Utkin VN
Antibiot Khimioter; 1994 Jan; 39(1):42-6. PubMed ID: 8060195
[TBL] [Abstract][Full Text] [Related]
9. [Determination of the antiproliferative activity of human recombinant interferon (reaferon) on diploid human cells].
Svistunova EV; Denisov LA
Antibiot Khimioter; 1988 Jul; 33(7):513-5. PubMed ID: 3190345
[TBL] [Abstract][Full Text] [Related]
10. [The results of clinical trials and the prospects of using the Soviet preparation of human recombinant interferon alpha-2 (reaferon) in medical practice].
Kalinin IuT; Vorob'ev AA; Bumialis VV; Denisov LA; Parfenov VV; Klenova AV; Ianulaĭtis AA; Ershov FI; Marchenko VI; Malinovskaia VV
Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):61-7. PubMed ID: 2256404
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
[TBL] [Abstract][Full Text] [Related]
12. [The clinico-laboratory dynamics in the reaferon treatment of glomerulonephritis patients with the nephrotic syndrome].
Shishkin AN; Sosunov AV; Romanova VI; Korneeva EP; Orlov VA
Ter Arkh; 1992; 64(6):29-32. PubMed ID: 1279826
[TBL] [Abstract][Full Text] [Related]
13. [The use of reaferon in treating patients with protracted viral hepatitis].
Kokoreva LN; Zmyzgova AV; Nazarenko IV
Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of 2,5-oligoadenylate synthetase and protein kinase activities in clinical studies of larifan and recombinant interferon alpha in volunteers].
Sokolova TM; Nosik NN; Lopatina OA; Krylov VF
Antibiot Khimioter; 1991 Jul; 36(7):42-5. PubMed ID: 1953190
[TBL] [Abstract][Full Text] [Related]
15. [Disordered interferon status in patients with urticaria and angioneurotic edema against a background of frequent ARVI: its correction with reaferon].
Belostotskaia OI; Grigorian SS; Poroshina IuA; Ivanova LA; Gervazieva VB
Vopr Virusol; 1989; 34(2):176-80. PubMed ID: 2474903
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of exogenous and endogenous interferonization in preventing influenza].
Ershov FI; Grigorian SS; Semenenko TA; Malinovskaia VV; Tarasenko OA; Agafonov VI; Prozorovskiĭ SV
Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):42-5. PubMed ID: 1724860
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental genital herpes with liposomal interferon.
Kobrinskii GD; Mel'nikov VR; Kulakov VN; L'vov ND; Bolotin IM; Barinskii IF
Biomed Sci; 1991; 2(1):29-32. PubMed ID: 1912245
[TBL] [Abstract][Full Text] [Related]
18. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration].
Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL
Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904
[TBL] [Abstract][Full Text] [Related]
19. [The effect of reaferon and alpha-tocopherol on lipid peroxidation in experimental influenza].
Pertseva NG; Ananenko AA; Malinovskaia VV; Klembovskiĭ AI; Burova VIa; Meshkova EN; Kleĭmenova NV
Vopr Virusol; 1995; 40(2):59-62. PubMed ID: 7762231
[TBL] [Abstract][Full Text] [Related]
20. [The results of preclinical trials of the Soviet recombinant preparation of human interferon alpha-2 (reaferon)].
Kalinin IuT; Vorob'ev AA; Bumialis VV; Denisov LA; Parfenov VV; Klenova AV; Ianulaĭtis AA; Ershov FI; Marchenko VI; Malinovskaia VV
Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):93-7. PubMed ID: 2220228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
